Nasdaq:US$15.21 (+0.37) | HKEX:HK$25.10 (+0.95) | AIM:£2.31 (+0.11)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 9 Oct 2013

Chi-Med’s Pharmaceutical R&D Business – Analyst & Investor Briefing